October 16, 2006

1 Min Read
SupplySide Supplement Journal logo in a gray background | SupplySide Supplement Journal

DECATUR, Ill.—Sabinsa Corp. has settled a patent infringement lawsuit filed against it by ADM, which accused Sabinsa of using ADM’s patented technology by unlawfully making, using, offering for sale, selling and/or importing its GENIMAX® soy-based isoflavone products. Sabinsa agreed ADM’s patents were valid and enforceable, and conceded its GENIMAX products infringed the patents. However, the agreement also declares Sabinsa’s infringement was unintentional and not willful. Sabinsa has agreed to discontinue making or selling the infringing product in the United States.

For more information, visit ADM at www.admworld.com or SupplySide West Booth #8001-8005; or Sabinsa at www.sabinsa.com or Booth #6007-6009.

Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like